(1)
BEKADJA, M. A. OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterr J Hematol Infect Dis 2017, 9, e2017062.